Aller au contenu principal
Profil bibliographique

Linda Chen

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

249Publications signalées
6312Citations signalées
6Affiliations récentes

Les institutions déclarées

Les domaines associés

Renal Transplantation Outcomes and TreatmentsHead and Neck Cancer StudiesBrain Metastases and TreatmentOrgan Transplantation Techniques and OutcomesOrgan Donation and Transplantation

Les publications récentes

2026 article OpenAlex

Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Hao-Shen Cheng, Irini Yacoub, Winston Wong, Lara A. Dunn et autres

ABSTRACT This retrospective study compared the efficacy and toxicity of concurrent triweekly versus weekly cisplatin in patients with previously untreated, biopsy‐proven NPC who received definitive CRT followed by adjuvant chemotherapy. Patients with distant metastasis, Karnofsky Performance Status < 80, induction chemotherapy, or …

us (code pays fourni par la source)

0 citations International Journal of Cancer
Accès ouvert 2026 article OpenAlex

CLTR-10 PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES (SOLARA)

Colette Shen, Yara Abdou, Linda Chen, Mina Lobbous et autres

Abstract Purpose Outcomes for patients with HER2-negative breast cancer with brain metastases remain poor. Therapeutic strategies that enhance radiation-induced DNA damage and anti-tumor immune response may improve intracranial control. We evaluated toxicity and intracranial disease control in patients receiving combination stereotactic radiosurgery …

us, in (code pays fourni par la source)

0 citations Neuro-Oncology Advances
2026 conference-abstract OpenAlex

A phase II, multicenter, single-arm clinical trial of response-adapted definitive radiotherapy and cemiplimab-rwlc immunotherapy for locally advanced, unresectable cutaneous squamous cell carcinoma: RAMPART.

Christopher Andrew Barker, Ryan Michael Lanning, Shlomo A. Koyfman, Jay Justin Liao et autres

9506 Background: Locally advanced (T3-4/N+/M0) and unresectable cutaneous squamous cell carcinoma (LAUCSCC) patients (pts) have been historically treated with definitive radiotherapy (RT) +/- chemotherapy, yielding poor outcomes (18m progression-free survival [PFS] rates of ~38%). More recently, anti-PD1 immunotherapy with cemiplimab (cemi) led …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma

Fan Yang, Edward Christopher Dee, Annu Singh, Yingzhi Wu et autres

Importance: Osteoradionecrosis (ORN) is a potentially debilitating late complication of radiotherapy (RT) for head and neck cancer. While proton therapy offers superior dose conformality, its impact on ORN risk remains uncertain, particularly in patients with oropharyngeal squamous cell carcinoma (OPSCC). Objective: To …

us, th, ca (code pays fourni par la source)

9 citations JAMA Otolaryngology–Head & Neck Surgery
2025 conference-abstract OpenAlex

Real-world chronic lymphocytic leukemia (CLL)–specific biomarker testing patterns and frontline treatment patterns in patients with CLL/small lymphocytic lymphoma (SLL)

Tim Reynolds, William Ye, Linda Chen, Mohammad Reza Eskandari et autres

Abstract Introduction: CLL/SLL is the most common leukemia in adults in the United States, with ~21,000 cases diagnosed annually. National Comprehensive Cancer Network (NCCN) guidelines recommend testing for certain prognostic variables prior to initiation of CLL/SLL treatment (tx). For patients (pts) with …

pt, us, py (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 article OpenAlex

The Use of Proton Radiation in the Management of Adenoid Cystic Carcinoma

Irini Ihab Yacoub, Achraf A. Shamseddine, Daniel Kallini, Nader Mohamed et autres

Purpose/Objectives: Adenoid cystic carcinoma (ACC) of the head and neck is a rare malignancy with a prolonged but infiltrative course, marked by perineural invasion and high risk of local recurrence and distant metastases. The standard of care for head/neck ACC is surgery …

us (code pays fourni par la source)

1 citation International Journal of Particle Therapy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.